Immunic AG | WebDisclosure

Basculer en Français

10619	Companies
225690	Keywords
154256	Articles
119426	Press releases

Home
Companies
Immunic AG

PRESS RELEASE

published on 02/04/2026 at 12:30, 4 months 19 days ago

Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to present additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, reinforcing potential in Progressive Multiple Sclerosis. Latest research findings to be shared at event

Immunic Vidofludimus Calcium Progressive Multiple Sclerosis Phase 2 CALLIPER Trial ACTRIMS Forum 2026
BRIEF

published on 01/07/2026 at 12:35, 5 months 16 days ago

Bilan d'Immunic 2025 : progrès et perspectives d'avenir

Vidofludimus Calcium Neuroprotection Essais Cliniques Sur La Sclérose En Plaques Réalisations Immunitaires Étapes Clés De La Biotechnologie
BRIEF

published on 01/07/2026 at 12:35, 5 months 16 days ago

Immunic Reviews 2025 Progress and Sets Sights on Future Goals

Vidofludimus Calcium Neuroprotection Multiple Sclerosis Trials Immunic Accomplishments Biotechnology Milestones
PRESS RELEASE

published on 01/07/2026 at 12:30, 5 months 16 days ago

Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic Inc. highlights its 2025 accomplishments & upcoming milestones including phase 3 trials for Vidofludimus Calcium in relapsing Multiple Sclerosis, positive data in Progressive MS, & potential for IMU-856 in weight management

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium IMU-856 2025 Accomplishments
BRIEF

published on 11/26/2025 at 12:35, 6 months 27 days ago

Immunic to Join Evercore ISI Healthcare Conference in December

Biotechnology Immunic Investor Meetings Healthcare Conference Neurologic Diseases
BRIEF

published on 11/26/2025 at 12:35, 6 months 27 days ago

Immunic participera à la conférence Evercore ISI Healthcare en décembre

Biotechnologie Conférence Sur Les Soins De Santé Immunitaire Maladies Neurologiques Réunions Avec Les Investisseurs
PRESS RELEASE

published on 11/26/2025 at 12:30, 6 months 27 days ago

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to participate in the 8th Annual Evercore ISI Healthcare Conference in December. Dr. Daniel Vitt to speak at fireside chat on novel oral therapies for neurologic and gastrointestinal diseases

Gastrointestinal Diseases Immunic Neurologic Diseases Evercore ISI Healthcare Conference Daniel Vitt
BRIEF

published on 11/13/2025 at 12:35, 7 months 10 days ago

Immunic, Inc. Announces Third Quarter 2025 Financial Results and Updates

Financial Results Clinical Trials Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium
BRIEF

published on 11/13/2025 at 12:35, 7 months 10 days ago

Immunic, Inc. annonce ses résultats financiers et ses mises à jour pour le troisième trimestre 2025

Résultats Financiers Essais Cliniques Sclérose En Plaques Vidofludimus Calcium Immunique, Inc.
PRESS RELEASE

published on 11/13/2025 at 12:30, 7 months 10 days ago

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. reports Q3 2025 financial results and provides corporate update, highlighting vidofludimus calcium's therapeutic potential in multiple sclerosis. Phase 3 ENSURE trial data expected by 2026

Financial Results Immunic Inc. Vidofludimus Calcium Phase 3 Trials MS Therapy

Accesswire

Published on 06/24/2026 at 00:00, 20 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 35 minutes ago

Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 1 hour ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 1 hour 5 minutes ago

EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/23/2026 at 23:00, 1 hour 20 minutes ago

International Battery Metals Ltd. Announces RSU Grant

View all ACCESSWIRE

EQS Group

Published on 06/23/2026 at 22:20, 2 hours ago

Saudi Properties Portal to Accept Applications for Foreign Real Estate Ownership
Published on 06/23/2026 at 20:15, 4 hours 5 minutes ago

EQS-Adhoc: OHB SE resolves on the issue of 1,605,388 new shares representing the first tranche of the up to 8.86% capital increase with subscription rights
Published on 06/23/2026 at 18:59, 5 hours 21 minutes ago

Holding(s) in Company
Published on 06/23/2026 at 18:30, 5 hours 50 minutes ago

IEVA GROUP: COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ANNUELLE DU 23 JUIN 2026
Published on 06/23/2026 at 17:55, 6 hours 25 minutes ago

ABO Energy ABO Energy drives strategic development and future financing solution forward

Les Echos

Published on 06/23/2026 at 19:47, 4 hours 32 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 4 hours 32 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 5 hours 10 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 5 hours 10 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 5 hours 47 minutes ago

Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix

View all LES ECHOS COMFI WIRE